Cara Therapeutics Inc - AnnualReports.com

Most Recent Annual Report

2017 Annual Report and Form 10K

Cara Therapeutics Inc has reached its limit for free report views.

PDF
Form 10K (HTML)

Cara Therapeutics Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Archived Annual Reports

- 2016 Annual Report
- PDF
- 2015 Annual Report
- PDF
- 2014 Annual Report
- PDF
Show 1 more archive
- 2013 Annual Report
- PDF

About Cara Therapeutics Inc

11-50 Employees

Based in Stamford, Connecticut

Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities designed to alleviate pain by selectively targeting kappa opioid receptors. Its lead product candidate includes intravenous CR845, which has completed Phase 2 clinical trials for the treatment acute postoperative pain in adult patients, as well as in Phase 2 clinical trials for the treatment of uremic pruritus disease.

Looking for Other Annual Reports?